About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

TERMINATEDNA

Effect of Use of Straw on Tolerability and Quality of Split Dose 4l-PEG Preparation

NCT02317731•Yale University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Colon Cancer

Interventions

Straw

Locations

1

United States

Locations (1)

Section of Digestive Diseases, Temple Medical Center

New Haven, Connecticut, United States

Key Dates

Start Date

December 1, 2014

Primary Completion Date

November 1, 2015

Completion Date

November 1, 2015

Last Updated

April 18, 2016

Related Studies

RECRUITINGPhase 1

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Advanced Breast CarcinomaAdvanced Colon Carcinoma+38 more

Resilience and Equity in Aging, Cancer, and Health (REACH)

NCT04674267

Gastric CancerColon Cancer+4 more

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

NCT04668872

Colon Cancer Liver MetastasisColon Cancer+4 more

RECRUITINGPhase 2

Phase II Trial of Lung Chemoemobolization

NCT05672108

Lung Non-Small Cell CarcinomaMediastinal Neoplasm+5 more

RECRUITINGPhase 1

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

NCT07321106

Colorectal CancerColorectal Cancer (CRC)+5 more

RECRUITINGPhase 1/2

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695

Solid Tumor, AdultColorectal Cancer+18 more

View all related studies

Sponsors

Lead Sponsor

Yale University

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 18, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions